These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 3105837

  • 1. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization.
    White DJ, Nancollas GH.
    Calcif Tissue Int; 1987 Feb; 40(2):79-84. PubMed ID: 3105837
    [Abstract] [Full Text] [Related]

  • 2. Triamterene and renal stone formation.
    White DJ, Nancollas GH.
    J Urol; 1982 Mar; 127(3):593-7. PubMed ID: 7062445
    [Abstract] [Full Text] [Related]

  • 3. Kinetic factors influencing the dissolution behavior of calcium oxalate renal stones: a constant composition study.
    White DJ, Coyle-Rees M, Nancollas GH.
    Calcif Tissue Int; 1988 Nov; 43(5):319-27. PubMed ID: 3145798
    [Abstract] [Full Text] [Related]

  • 4. Triamterene urolithiasis: solubility, pk, effect on crystal formation, and matrix binding of triamterene and its metabolites.
    Werness PG, Bergert JH, Smith LH.
    J Lab Clin Med; 1982 Feb; 99(2):254-62. PubMed ID: 7061920
    [Abstract] [Full Text] [Related]

  • 5. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO, Schmiedl A, Manoharan M.
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [Abstract] [Full Text] [Related]

  • 6. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berthézène P, Dupuy P, Vazi A, Berland Y, Dagorn JC, Verdier JM.
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [Abstract] [Full Text] [Related]

  • 7. Oxalate crystallization in the kidney in the presence of hyperuricemia.
    Noda S, Hayashi K, Eto K.
    Scanning Microsc; 1989 Sep; 3(3):829-35; discussion 835-6. PubMed ID: 2617264
    [Abstract] [Full Text] [Related]

  • 8. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG.
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [Abstract] [Full Text] [Related]

  • 9. Triamterene nephrolithiasis.
    Ettinger B, Oldroyd NO, Sörgel F.
    JAMA; 1980 Nov 28; 244(21):2443-5. PubMed ID: 7431573
    [Abstract] [Full Text] [Related]

  • 10. Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?
    Wesson JA, Kolbach-Mandel AM, Hoffmann BR, Davis C, Mandel NS.
    Urolithiasis; 2019 Dec 28; 47(6):521-532. PubMed ID: 30993355
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of factors involved in calcium stone formation.
    Abraham PA, Smith CL.
    Miner Electrolyte Metab; 1987 Dec 28; 13(3):201-8. PubMed ID: 3627051
    [Abstract] [Full Text] [Related]

  • 12. [The effect of takusha and kagosou on calcium oxalate renal stones in rats].
    Yamaguchi S, Jihong L, Utsunomiya M, Yoshioka T, Okuyama A, Koide T, Sugiyama K.
    Hinyokika Kiyo; 1995 Jun 28; 41(6):427-31. PubMed ID: 7645450
    [Abstract] [Full Text] [Related]

  • 13. Calcium stone disease: a multiform reality.
    Trinchieri A, Castelnuovo C, Lizzano R, Zanetti G.
    Urol Res; 2005 Jun 28; 33(3):194-8. PubMed ID: 15714335
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL.
    Kidney Int; 2002 Mar 28; 61(3):975-87. PubMed ID: 11849452
    [Abstract] [Full Text] [Related]

  • 16. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate.
    Khan SR.
    J Urol; 1997 Jan 28; 157(1):376-83. PubMed ID: 8976301
    [Abstract] [Full Text] [Related]

  • 17. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D, Kalaiselvi P, Varalakshmi P.
    Nephron Physiol; 2004 Jan 28; 97(1):p23-30. PubMed ID: 15153748
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B.
    Ther Umsch; 2003 Feb 28; 60(2):79-87. PubMed ID: 12649986
    [Abstract] [Full Text] [Related]

  • 20. Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis.
    Porile JL, Asplin JR, Parks JH, Nakagawa Y, Coe FL.
    J Am Soc Nephrol; 1996 Apr 28; 7(4):602-7. PubMed ID: 8724894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.